JanOne Inc JAN

NAS: JAN | ISIN: US47089W1045   3/05/2024
3,900 USD (-0,76%)
(-0,76%)   3/05/2024

15 maart 2024 · JanOne Regains Compliance with Nasdaq's Listing Requirements · Persbericht

21 september 2023 · JanOne to Present at the Dawson James 8th Annual Investment Conference · Persbericht

31 augustus 2023 · JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference · Persbericht

29 augustus 2023 · JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain · Persbericht

25 augustus 2023 · JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting · Persbericht

22 augustus 2023 · JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules · Persbericht

19 augustus 2023 · JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules · Persbericht

18 augustus 2023 · JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting · Persbericht

28 juni 2023 · JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain · Persbericht

18 april 2023 · JanOne Completes Pre-IND Meeting with FDA on Jan123 · Persbericht

13 april 2023 · JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023 · Persbericht

24 maart 2023 · JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-Market · Persbericht

23 maart 2023 · JanOne Welcomes John Bonfiglio -- Veteran Biotech Executive, Deal Maker and Strategist -- to Top Management Team · Persbericht

23 maart 2023 · JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-Market · Persbericht

22 maart 2023 · JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm Businesses · Persbericht

22 februari 2023 · JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians · Persbericht

26 januari 2023 · JanOne Charts Ambitious Strategic Course for Non-Addictive Pain Management · Persbericht

10 januari 2023 · JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC · Persbericht

16 september 2022 · JanOne Inc. Executes Term Sheet to Acquire Soin Therapeutics LLC · Persbericht

5 juli 2022 · ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website · Persbericht

Mijn selecties